Michael Adamek

Michael Adamek

Auto-generated profile, based on publicly available information

Michael Adamek

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo n. 542/2, 160 00 Prague 6, Czech Republic

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JSJindrich Sedlacek
Jindrich Sedlacek
ZSZuzana Smahelova
Zuzana Smahelova
MAMichael Adamek
Michael Adamek
DSDominika Subova
Dominika Subova
LSLucie Svobodova
Lucie Svobodova
KSKlara Grantz Saskova
Klara Grantz Saskova
Intracellular protein aggregation causes proteotoxic stress, underlying highly debilitating neurodegenerative disorders in parallel with decreased proteasome activity. Nevertheless, under such stress conditions, the expression of proteasome subunits is upregulated by Nuclear Factor Erythroid 2-related factor 1 (NRF1), a transcription factor that is encoded by NFE2L1. Activating the NRF1 pathway could accordingly delay the onset of neurodegenerative and other disorders with impaired cell proteostasis. Here, we present a series of small-molecule compounds based on bis(phenylmethylen)cycloalkanones and their heterocyclic analogues, identified via targeted library screening, that can induce NRF1-dependent downstream events, such as proteasome synthesis, heat shock response, and autophagy, in both model cell lines and Caenorhabditis elegans strains. These compounds increase proteasome activity and decrease the size and number of protein aggregates without causing any cellular stress or inhibiting the ubiquitin-proteasome system (UPS). Therefore, our compounds represent a new promising therapeutic approach for various protein conformational diseases, including the most debilitating neurodegenerative diseases.

22 October 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
ZSZuzana Smahelova
Zuzana Smahelova
LSLucie Svobodova
Lucie Svobodova
JSJindrich Sedlacek
Jindrich Sedlacek
MAMichael Adamek
Michael Adamek
MPMarketa Pimkova Polidarova
Marketa Pimkova Polidarova
KSKlara Grantz Saskova
Klara Grantz Saskova
NFE2L1 activator enhancing proteasome, heat shock, and autophagy pathways.